Gillian M Craig1, Alimuddin Zumla2. 1. School of Health Sciences, City University London, Northampton Square, London, EC1 V 0HB, UK. Electronic address: Gill.Craig.1@city.ac.uk. 2. Department of Infection, Division of Infection and Immunity, Centre for Clinical Microbiology, University College London, and NIHR Biomedical Research Centre, University College London Hospitals, London, UK.
Abstract
OBJECTIVES: There is scant qualitative research into the experiences of tuberculosis (TB) treatment in urban risk groups with complex health and social needs in the UK. This study aimed to describe the social context of adherence to treatment in marginalized groups attending a major TB centre in London. METHODS: A qualitative cross-sectional study was performed using semi-structured interviews with patients receiving treatment for TB. Analytical frameworks aimed to reflect the role of broader social structures in shaping individual health actions. RESULTS: There were 17 participants; the majority were homeless and had complex medical and social needs, including drug and alcohol use or immigration problems affecting entitlement to social welfare. Participants rarely actively chose not to take their medication, but described a number of social and institutional barriers to adherence and their need for practical support. Many struggled with the physical aspects of taking medication and the side effects. Participants receiving directly observed therapy (DOT) reported both positive and negative experiences, reflecting the type of DOT provider and culture of the organization. CONCLUSIONS: There is a need for integrated care across drug, alcohol, HIV, and homeless services in order to address the complex clinical co-morbidities and social needs that impact on the patient's ability to sustain a course of treatment.
OBJECTIVES: There is scant qualitative research into the experiences of tuberculosis (TB) treatment in urban risk groups with complex health and social needs in the UK. This study aimed to describe the social context of adherence to treatment in marginalized groups attending a major TB centre in London. METHODS: A qualitative cross-sectional study was performed using semi-structured interviews with patients receiving treatment for TB. Analytical frameworks aimed to reflect the role of broader social structures in shaping individual health actions. RESULTS: There were 17 participants; the majority were homeless and had complex medical and social needs, including drug and alcohol use or immigration problems affecting entitlement to social welfare. Participants rarely actively chose not to take their medication, but described a number of social and institutional barriers to adherence and their need for practical support. Many struggled with the physical aspects of taking medication and the side effects. Participants receiving directly observed therapy (DOT) reported both positive and negative experiences, reflecting the type of DOT provider and culture of the organization. CONCLUSIONS: There is a need for integrated care across drug, alcohol, HIV, and homeless services in order to address the complex clinical co-morbidities and social needs that impact on the patient's ability to sustain a course of treatment.
Authors: Bhushan Dattatray Kamble; Sunil Kumar Singh; Sumit Jethani; Vinoth Gnana D Chellaiyan; Bhabani Prasad Acharya Journal: J Family Med Prim Care Date: 2020-08-25
Authors: Rosiane Davina da Silva; Fernanda Darliane Tavares de Luna; Aguinaldo José de Araújo; Edwirde Luiz Silva Camêlo; Maria Rita Bertolozzi; Paula Hino; Sheylla Nadjane Batista Lacerda; Sayonara Maria Lia Fook; Tânia Maria Ribeiro Monteiro de Figueiredo Journal: BMC Public Health Date: 2017-09-19 Impact factor: 3.295
Authors: Patrick Nguipdop-Djomo; Laura C Rodrigues; Peter G Smith; Ibrahim Abubakar; Punam Mangtani Journal: Sci Rep Date: 2020-03-27 Impact factor: 4.379
Authors: Aaron S Karat; Annie S K Jones; Ibrahim Abubakar; Colin N J Campbell; Amy L Clarke; Caroline S Clarke; Marcia Darvell; Adam T Hill; Robert Horne; Heinke Kunst; Mike Mandelbaum; Ben G Marshall; Ceri McSparron; Ananna Rahman; Helen R Stagg; Jacqui White; Marc C I Lipman; Karina Kielmann Journal: J Clin Tuberc Other Mycobact Dis Date: 2021-03-29
Authors: Angella Musiimenta; Wilson Tumuhimbise; Esther C Atukunda; Aaron T Mugaba; Conrad Muzoora; Mari Armstrong-Hough; David Bangsberg; J Lucian Davis; Jessica E Haberer Journal: Tuberc Res Treat Date: 2020-01-07